Widely recognized for his research on vascular disease, Abraham and his team specifically study heme oxygenase, the most potent antioxidant gene in the human body. The team’s research also includes an emphasis on translational medicine. Abraham is currently the principal investigator on two National Institutes of Health (NIH) grants focusing on stem cells-heme oxygenase, hormonal regulation of blood pressure, obesity and diabetes. Over his 30-year-plus career, Abraham has served as principal investigator or co-investigator on grants or projects totaling more than $17.3 million. As project leader for a program project in pharmacology, he has worked on five grants with total NIH funding of more than $60 million, bringing his total career grant support to more than $77 million.
Dr. Abraham has served as an invited lecturer internationally, including in China, Germany, Hungary, Israel, Italy, Japan, Sweden, Copenhagen, Czech Republic and Poland. He is the author or co-author of more than 300 original articles and has mentored numerous postdoctoral and graduate students. He is a Fellow of the American Heart Association.